By characterizing the molecular consequences of HSP90 inhibition in BL cells, Walter et al. provided evidence that SYK is a client protein of HSP90, and that the BCR signaling-dependent phosphorylation of Hsp90 is required for this interaction [19]. This evidence concerns the gene HSP90AA1 and Burkitt lymphoma.